ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Relay Therapeutics Inc

Relay Therapeutics Inc (RLAY)

3,245
0,055
( 1,72% )
Aktualisiert: 16:25:55
Fortg. Diagramm

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
3,245
Gebot
3,24
Fragen
3,25
Volumen
190.531
3,15 Tagesbereich 3,26
3,02 52-Wochen-Bereich 10,72
Marktkapitalisierung
Handelsende
3,19
Handelsbeginn
3,21
Letzte Trade
100
@
3.245
Letzter Handelszeitpunkt
16:25:55
Finanzvolumen
US$ 610.005
VWAP
3,2016
Durchschnittliches Volumen (3 Mio.)
2.366.131
Ausgegebene Aktien
169.521.849
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,59
Gewinn pro Aktie (EPS)
-2,02
Erlöse
31,97M
Nettogewinn
-341,97M

Über Relay Therapeutics Inc

Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, i... Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Relay Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RLAY. The last closing price for Relay Therapeutics was US$3,19. Over the last year, Relay Therapeutics shares have traded in a share price range of US$ 3,02 to US$ 10,72.

Relay Therapeutics currently has 169.521.849 shares in issue. The market capitalisation of Relay Therapeutics is US$540,77 million. Relay Therapeutics has a price to earnings ratio (PE ratio) of -1.59.

RLAY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.455-12.29729729733.73.8653.0226906833.3264259CS
4-1.385-29.91360691144.634.863.0216891283.71732188CS
12-1.655-33.77551020414.95.993.0223661314.31633594CS
26-3.145-49.21752738656.3910.723.0223466295.66804734CS
52-6.805-67.711442786110.0510.723.0217693946.22935395CS
156-17.295-84.201557935720.5435.363.02136874711.56052811CS
260-30.735-90.450264861733.9864.373.02109078216.09727202CS

RLAY - Frequently Asked Questions (FAQ)

What is the current Relay Therapeutics share price?
The current share price of Relay Therapeutics is US$ 3,245
How many Relay Therapeutics shares are in issue?
Relay Therapeutics has 169.521.849 shares in issue
What is the market cap of Relay Therapeutics?
The market capitalisation of Relay Therapeutics is USD 540,77M
What is the 1 year trading range for Relay Therapeutics share price?
Relay Therapeutics has traded in the range of US$ 3,02 to US$ 10,72 during the past year
What is the PE ratio of Relay Therapeutics?
The price to earnings ratio of Relay Therapeutics is -1,59
What is the cash to sales ratio of Relay Therapeutics?
The cash to sales ratio of Relay Therapeutics is 16,97
What is the reporting currency for Relay Therapeutics?
Relay Therapeutics reports financial results in USD
What is the latest annual turnover for Relay Therapeutics?
The latest annual turnover of Relay Therapeutics is USD 31,97M
What is the latest annual profit for Relay Therapeutics?
The latest annual profit of Relay Therapeutics is USD -341,97M
What is the registered address of Relay Therapeutics?
The registered address for Relay Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Relay Therapeutics website address?
The website address for Relay Therapeutics is www.relaytx.com
Which industry sector does Relay Therapeutics operate in?
Relay Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GVVisionary Holdings Inc
US$ 2,30
(78,29%)
78,74M
CMRXChimerix Inc
US$ 8,405
(69,46%)
92,64M
ARBBARB IOT Group Ltd
US$ 0,792651
(52,43%)
52,26M
CDXCChromaDex Corporation
US$ 8,4986
(51,76%)
6,31M
PRTSCarParts com Inc
US$ 1,215
(37,88%)
4,25M
CUTRCutera Inc
US$ 0,1666
(-47,01%)
5,71M
LBGJLi Bang International Corporation Inc
US$ 1,30
(-35,00%)
114,77k
XCURExicure Inc
US$ 10,515
(-26,37%)
65,75k
CRWLGranite Shares 2x Long CRWD Daily ETF
US$ 22,90
(-21,06%)
276,91k
TIVCTivic Health Systems Inc
US$ 0,2741
(-19,36%)
796,03k
ADTXAditxt Inc
US$ 0,055
(10,44%)
101,65M
CMRXChimerix Inc
US$ 8,41
(69,56%)
93,88M
GVVisionary Holdings Inc
US$ 2,2901
(77,53%)
82,22M
NVDANVIDIA Corporation
US$ 115,54
(-0,39%)
73,88M
SLXNSilexion Therapeutics Corporation
US$ 1,425
(28,38%)
70,72M

RLAY Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen